<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0409-0124-01
</NDCCode>
<PackageDescription>
1 VIAL, SINGLE-USE in 1 CARTON (0409-0124-01) > 25 mL in 1 VIAL, SINGLE-USE
</PackageDescription>
<NDC11Code>
00409-0124-01
</NDC11Code>
<ProductNDC>
0409-0124
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Doxorubicin Hydrochloride
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Doxorubicin Hydrochloride
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
</DosageFormName>
<RouteName>
INTRA-ARTERIAL; INTRAVENOUS; INTRAVESICAL
</RouteName>
<StartMarketingDate>
20160418
</StartMarketingDate>
<EndMarketingDate>
20171231
</EndMarketingDate>
<MarketingCategoryName>
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Hospira, Inc.
</LabelerName>
<SubstanceName>
DOXORUBICIN HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
2
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-01-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20171231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>